ATE229650T1 - Verfahren zur diagnose von diabetes und praediabetischer bedingungen - Google Patents
Verfahren zur diagnose von diabetes und praediabetischer bedingungenInfo
- Publication number
- ATE229650T1 ATE229650T1 AT94906796T AT94906796T ATE229650T1 AT E229650 T1 ATE229650 T1 AT E229650T1 AT 94906796 T AT94906796 T AT 94906796T AT 94906796 T AT94906796 T AT 94906796T AT E229650 T1 ATE229650 T1 AT E229650T1
- Authority
- AT
- Austria
- Prior art keywords
- gad
- pct
- patient
- preediabetic
- conditions
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 102000008214 Glutamate decarboxylase Human genes 0.000 abstract 8
- 108091022930 Glutamate decarboxylase Proteins 0.000 abstract 8
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 210000002966 serum Anatomy 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 abstract 1
- 102000001708 Protein Isoforms Human genes 0.000 abstract 1
- 108010029485 Protein Isoforms Proteins 0.000 abstract 1
- 239000000539 dimer Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Rehabilitation Therapy (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPL716893 | 1993-02-09 | ||
| PCT/AU1994/000056 WO1994018568A1 (en) | 1993-02-09 | 1994-02-09 | Methods for the diagnosis of diabetes and prediabetic conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE229650T1 true ATE229650T1 (de) | 2002-12-15 |
Family
ID=3776693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94906796T ATE229650T1 (de) | 1993-02-09 | 1994-02-09 | Verfahren zur diagnose von diabetes und praediabetischer bedingungen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5770381A (de) |
| EP (1) | EP0686262B1 (de) |
| JP (1) | JP3510889B2 (de) |
| AT (1) | ATE229650T1 (de) |
| CA (1) | CA2155677A1 (de) |
| DE (1) | DE69431874D1 (de) |
| IL (1) | IL108587A (de) |
| NZ (1) | NZ261541A (de) |
| SG (1) | SG45161A1 (de) |
| TW (1) | TW305936B (de) |
| WO (1) | WO1994018568A1 (de) |
| ZA (1) | ZA94845B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5821334A (en) * | 1996-01-26 | 1998-10-13 | Vanderbilt University | Insulin-dependent diabetes mellitus-specific chimeric polypeptides |
| FR2759701B1 (fr) * | 1997-02-19 | 1999-06-04 | Inst Nat Sante Rech Med | Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques |
| AU3958999A (en) * | 1999-06-01 | 2000-12-18 | Kyokuto Pharmaceutical Industrial Co., Ltd. | Method for assaying anti-gad antibody and kit |
| EP2836845B1 (de) | 2012-04-13 | 2018-05-09 | DiabetOmics, Inc. | Biomarker für schwangerschaftsdiabetes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6682906B1 (en) * | 1990-09-21 | 2004-01-27 | The Regents Of The University Of California | Cloned glutamic acid decarboxylase |
| WO1992014485A1 (en) * | 1991-02-22 | 1992-09-03 | Amrad Corporation Limited | A method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases |
| WO1992019972A1 (en) * | 1991-05-03 | 1992-11-12 | Novo Nordisk A/S | Islet cell autoantigen (gad) for the detection of preclinical diabetes |
-
1994
- 1994-02-08 ZA ZA94845A patent/ZA94845B/xx unknown
- 1994-02-08 TW TW083101065A patent/TW305936B/zh active
- 1994-02-08 IL IL108587A patent/IL108587A/en not_active IP Right Cessation
- 1994-02-09 EP EP94906796A patent/EP0686262B1/de not_active Expired - Lifetime
- 1994-02-09 DE DE69431874T patent/DE69431874D1/de not_active Expired - Lifetime
- 1994-02-09 AT AT94906796T patent/ATE229650T1/de not_active IP Right Cessation
- 1994-02-09 JP JP51744894A patent/JP3510889B2/ja not_active Expired - Fee Related
- 1994-02-09 NZ NZ261541A patent/NZ261541A/en unknown
- 1994-02-09 US US08/495,584 patent/US5770381A/en not_active Expired - Fee Related
- 1994-02-09 CA CA002155677A patent/CA2155677A1/en not_active Abandoned
- 1994-02-09 WO PCT/AU1994/000056 patent/WO1994018568A1/en not_active Ceased
- 1994-02-09 SG SG1996000807A patent/SG45161A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3510889B2 (ja) | 2004-03-29 |
| IL108587A0 (en) | 1994-05-30 |
| EP0686262B1 (de) | 2002-12-11 |
| EP0686262A4 (de) | 1997-06-04 |
| JPH08506417A (ja) | 1996-07-09 |
| WO1994018568A1 (en) | 1994-08-18 |
| DE69431874D1 (de) | 2003-01-23 |
| US5770381A (en) | 1998-06-23 |
| EP0686262A1 (de) | 1995-12-13 |
| CA2155677A1 (en) | 1994-08-18 |
| TW305936B (de) | 1997-05-21 |
| SG45161A1 (en) | 1998-01-16 |
| NZ261541A (en) | 1996-09-25 |
| IL108587A (en) | 1998-01-04 |
| ZA94845B (en) | 1994-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bingley et al. | Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives | |
| DeRose et al. | Response of Paget's disease to porcine and salmon calcitonins: effects of long-term treatment | |
| Niemelä et al. | Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum | |
| Ooi et al. | Serum immune complexes in membranoproliferative and other glomerulonephritides | |
| ATE117806T1 (de) | Bestimmungsmethode für glykosyliertes hämoglobin. | |
| LU91015I2 (fr) | Recombinate (Rurioctocog alfa) dans toutes ses formes couvertes par le brevet de base | |
| DK557089A (da) | Proeve for type iii collagennedbrydning | |
| ATE223051T1 (de) | Verfahren zur diagnose gutartiger prostataerkrankungen | |
| CA2104225A1 (en) | Method for the diagnosis and treatment of glutamic acid decarboxylase autoantigen associated diseases | |
| AU577106B2 (en) | Test strip for recording daily blood glucose profiles | |
| DE69510336D1 (de) | Verfahren zur diagnose von praeklampsie | |
| Dybkaer | Unit" katal" for catalytic activity | |
| ATE68600T1 (de) | Satz und verfahren zur diagnose der iganephropathie. | |
| DE69204157D1 (de) | Verfahren zur bestimmung von anti-rns-antikörpern. | |
| DE69431874D1 (de) | Verfahren zur diagnose von diabetes und praediabetischer bedingungen | |
| Arevalo | Prevalence of familial dysalbuminemic hyperthyroxinemia in serum samples received for thyroid testing | |
| Hänsch et al. | Effect of aspirin on the complement system in vitro | |
| Ittyerah et al. | Coagulation factor XIII concentration in sickle-cell disease | |
| Gebhart et al. | A comparison of home glucose monitoring with determinations of hemoglobin A1c, total glycated hemoglobin, fructosamine, and random serum glucose in diabetic patients | |
| Yokokawa et al. | Presence of anti-DNA antibody in diabetes mellitus: its relation to the duration of diabetes and diabetic complications | |
| Walker et al. | Adjusted calcium conflict resolved? Differing effects on plasma total calcium of changes in plasma albumin after venous stasis or myocardial infarction | |
| DE59305225D1 (de) | Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern | |
| US5518886A (en) | Blood lead diagnostic assay | |
| SU1274682A1 (ru) | Способ диагностики сальмонеллеза у детей | |
| Kjellman et al. | Cognitive and affective functions in patients with affective disorders treated with lithium AN ASSESSMENT BY QUESTIONNAIRE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |